AI assistant
Sending…
Dermata Therapeutics, Inc. — Director's Dealing 2021
Sep 2, 2021
35467_dirs_2021-09-01_7c250609-f6b5-49d3-88bf-35f75d438e48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Dermata Therapeutics, Inc. (DRMA)
CIK: 0001853816
Period of Report: 2021-09-01
Reporting Person: Van Hoose Kyri K. (Chief Financial Officer)
More from Dermata Therapeutics, Inc.
Regulatory Filings
2026
Jun 4
Capital/Financing Update
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 22
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Feb 25
Major Shareholding Notification
2026
Feb 18
Major Shareholding Notification
2026
Feb 17